Rhenovia Pharma

About:

Rhenovia Pharma SAS is a French biotechnology company founded in 2007 by an international team that brings together managers from large

Website: http://rhenovia.com

Top Investors: Alsace Business Angels, SODIV ALSACE

Description:

Rhenovia Pharma SAS is a French biotechnology company founded in 2007 by an international team that brings together managers from large pharmaceutical companies and world experts in neuroscience and nervous system modeling. The company is the world leader in the application of biosimulation in the prevention and treatment of neurological, neurodegenerative and psychiatric disorders and diseases. Based in Mulhouse (France) and Cambridge (Massachusetts), Rhenovia has around twenty members of staff in France, Switzerland, Germany and the US.

Total Funding Amount:

930000 EUR

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Mulhouse, Alsace, France

Founded Date:

2007-05-03

Contact Email:

info(AT)rhenovia.com

Founders:

Jacques Baudry, Jan Kremers, Michel Baudry, PhD, Michel Faupel, Serge Bischoff

Number of Employees:

11-50

Last Funding Date:

2014-02-12

IPO Status:

Private

Industries:

© 2025 bioDAO.ai